Rationale and Design of a Phase 3b, Prospective, Randomized, Open Label, Blinded-Endpoint, Multicenter Trial of the Efficacy and Safety of Urokinase Thrombolysis Comparing with Antiplatelet Agents for Patients with Minor Stroke
INTERNATIONAL JOURNAL OF STROKE（2022）
Key words
Acute minor ischemic stroke,urokinase,intervention,efficacy,safety,protocol
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined